Brookstone Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.18M | Buy |
27,821
+2,942
| +12% | +$237K | 0.02% | 480 |
|
|
2026
Q1 | $2.16M | Buy |
24,879
+2,540
| +11% | +$243K | 0.02% | 450 |
|
|
2025
Q4 | $2.15M | Sell |
22,339
-26
| -0.1% | -$2.53K | 0.02% | 435 |
|
|
2025
Q3 | $2.13M | Sell |
22,365
-407
| -2% | -$37.4K | 0.03% | 429 |
|
|
2025
Q2 | $1.99M | Buy |
22,772
+2,509
| +12% | +$213K | 0.03% | 418 |
|
|
2025
Q1 | $1.82M | Buy |
20,263
+237
| +1% | +$21.2K | 0.03% | 430 |
|
|
2024
Q4 | $1.6M | Buy |
20,026
+2,049
| +11% | +$177K | 0.02% | 419 |
|
|
2024
Q3 | $1.62M | Sell |
17,977
-13,819
| -43% | -$1.16M | 0.02% | 412 |
|
|
2024
Q2 | $2.58M | Buy |
31,796
+2,623
| +9% | +$215K | 0.04% | 333 |
|
|
2024
Q1 | $2.54M | Sell |
29,173
-49,977
| -63% | -$4.27M | 0.05% | 322 |
|
|
2023
Q4 | $6.52M | Buy |
79,150
+4,609
| +6% | +$351K | 0.13% | 171 |
|
|
2023
Q3 | $5.39M | Buy |
74,541
+11,230
| +18% | +$940K | 0.12% | 176 |
|
|
2023
Q2 | $5.44M | Buy |
63,311
+586
| +0.9% | +$50.4K | 0.11% | 186 |
|
|
2023
Q1 | $5.15M | Buy |
62,725
+3,689
| +6% | +$301K | 0.1% | 182 |
|
|
2022
Q4 | $4.77M | Buy |
59,036
+21,311
| +56% | +$1.73M | 0.1% | 182 |
|
|
2022
Q3 | $3.03M | Buy |
37,725
+4,016
| +12% | +$361K | 0.07% | 223 |
|
|
2022
Q2 | $3.02M | Buy |
33,709
+11,859
| +54% | +$1.2M | 0.07% | 229 |
|
|
2022
Q1 | $2.44M | Buy |
21,850
+8,894
| +69% | +$940K | 0.05% | 266 |
|
|
2021
Q4 | $1.36M | Buy |
12,956
+2,967
| +30% | +$344K | 0.02% | 330 |
|
|
2021
Q3 | $1.22M | Buy |
9,989
+404
| +4% | +$52.3K | 0.02% | 350 |
|
|
2021
Q2 | $1.22M | Buy |
9,585
+2,217
| +30% | +$278K | 0.02% | 337 |
|
|
2021
Q1 | $870K | Buy |
7,368
+1,836
| +33% | +$215K | 0.03% | 271 |
|
|
2020
Q4 | $648K | Buy |
5,532
+460
| +9% | +$50.6K | 0.03% | 298 |
|
|
2020
Q3 | $527K | Buy |
5,072
+1,847
| +57% | +$185K | 0.02% | 267 |
|
|
2020
Q2 | $296K | Buy |
3,225
+285
| +10% | +$27.3K | 0.02% | 292 |
|
|
2020
Q1 | $265K | Buy |
2,940
+175
| +6% | +$18.6K | 0.02% | 271 |
|
|
2019
Q4 | $314K | Sell |
2,765
-352
| -11% | -$38.6K | 0.02% | 327 |
|
|
2019
Q3 | $339K | Buy |
3,117
+740
| +31% | +$77.2K | 0.02% | 321 |
|
|
2019
Q2 | $231K | Sell |
2,377
-76
| -3% | -$6.94K | 0.01% | 396 |
|
|
2019
Q1 | $223K | Buy |
+2,453
| New | +$220K | 0.01% | 362 |
|
|
2015
Q4 | – | Sell |
-1,540
| Closed | -$103K | – | 592 |
|
|
2015
Q3 | $103K | Hold |
1,540
| – | – | 0.02% | 268 |
|
|
2015
Q2 | $114K | Buy |
+1,540
| New | +$118K | 0.01% | 310 |
|
Other funds holding MDT
Brookstone Capital Management's MDT Position: Q2 2026 in Review
Brookstone Capital Management increased its Medtronic (MDT) stake by 12% in Q2 2026, buying an estimated $237K and bringing the position to 27,821 shares worth $2.18M. The position accounts for 0.02% of the portfolio, ranked #480.
Brookstone Capital Management first reported a position in MDT in Q2 2015 and has held it in 32 quarters since. The position peaked at $6.52M in Q4 2023. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Brookstone Capital Management held 27,821 shares of Medtronic worth $2.18M as of Q2 2026.
- Brookstone Capital Management bought 2,942 Medtronic shares in Q2 2026, an estimated $237K.
- Medtronic made up 0.02% of Brookstone Capital Management's portfolio in Q2 2026, its #480 holding.
- Brookstone Capital Management first reported a position in Medtronic in Q2 2015 and has held it in 32 quarters since.
- Brookstone Capital Management's Medtronic position peaked at $6.52M in Q4 2023.
- 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.